ZB
KIDS icon

Zions Bancorporation’s OrthoPediatrics KIDS Stock Holding History

Zions Bancorporation’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-141
Closed -$5.6K – 981
2022
Q4 		$5.6K Buy
+141
New +$5.87K ﹤0.01% 832

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Zions Bancorporation's KIDS Position: Q1 2023 in Review

Zions Bancorporation sold out of OrthoPediatrics (KIDS) in Q1 2023, closing a stake of 141 shares — an estimated $5.6K sold.

Zions Bancorporation first reported a position in KIDS in Q4 2022 and held it in 1 quarter. The position peaked at $5.6K in Q4 2022. 122 funds tracked by Wall St. Rank hold KIDS as of Q1 2023.

  • Zions Bancorporation reported no remaining OrthoPediatrics position as of Q1 2023 after selling out during the quarter.
  • Zions Bancorporation sold 141 OrthoPediatrics shares in Q1 2023, an estimated $5.6K.
  • Zions Bancorporation first reported a position in OrthoPediatrics in Q4 2022 and held it in 1 quarter.
  • Zions Bancorporation's OrthoPediatrics position peaked at $5.6K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.